Gerardo Santiago Toledo

Director, Cell Process Development at Autolus Therapeutics

Speaker

Gerardo Santiago Toledo is Director, Cell Process Development at Autolus Therapeutics. He joined Autolus in 2019 where he is involved in the design, characterisation and refinement of autologous CAR-T cell manufacturing processes for early-stage and late-stage programmes. Gerry has been involved in regulatory filings (BLA/MAA, IND/IMPD), CMC strategy, late-stage process development for obecabtegene-autoleucel (obe-cel) as well as doctoral supervision in collaboration with UCL Biochemical Engineering. He has a BSc in Biotechnology Engineering from Tecnologico de Monterrey and a PhD in Biochemical Engineering from University College London (UCL) related to investigating process parameters for a potential allogeneic cell therapy for neural regeneration.